Pulse Biosciences (PLSE) Common Equity (2020 - 2025)
Historic Common Equity for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $92.7 million.
- Pulse Biosciences' Common Equity rose 1713.99% to $92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.7 million, marking a year-over-year increase of 1713.99%. This contributed to the annual value of $114.9 million for FY2024, which is 15893.15% up from last year.
- Per Pulse Biosciences' latest filing, its Common Equity stood at $92.7 million for Q3 2025, which was up 1713.99% from $104.5 million recorded in Q2 2025.
- Over the past 5 years, Pulse Biosciences' Common Equity peaked at $118.5 million during Q1 2025, and registered a low of -$10.7 million during Q1 2023.
- In the last 5 years, Pulse Biosciences' Common Equity had a median value of $44.4 million in 2021 and averaged $49.4 million.
- Over the last 5 years, Pulse Biosciences' Common Equity had its largest YoY gain of 207330.96% in 2023, and its largest YoY loss of 15129.83% in 2023.
- Quarter analysis of 5 years shows Pulse Biosciences' Common Equity stood at $44.4 million in 2021, then plummeted by 105.07% to -$2.2 million in 2022, then soared by 2073.31% to $44.4 million in 2023, then skyrocketed by 158.93% to $114.9 million in 2024, then decreased by 19.3% to $92.7 million in 2025.
- Its Common Equity stands at $92.7 million for Q3 2025, versus $104.5 million for Q2 2025 and $118.5 million for Q1 2025.